Literature DB >> 15122803

Influenza virological surveillance in children: the use of the QuickVue rapid diagnostic test.

Fabrizio Pregliasco1, Simona Puzelli, Carolina Mensi, Giovanni Anselmi, Roberto Marinello, M Luisa Tanzi, Chiara Affinito, Maria C Zambon, Isabella Donatelli.   

Abstract

New rapid diagnostic methods are needed to identify influenza infections to improve virological surveillance usually undertaken with conventional time-consuming, complex, and even expensive laboratory methods. Another reason for using a rapid test is to avoid inappropriate therapy, particularly in children, where use of antibiotics inappropriately and high influenza-related rates of hospitalisation are described. During two winter seasons, the performance of the QuickVue Influenza test (QV) was evaluated in children under 14 presenting with influenza like illness, and compared the results with those obtained from sentinel network surveillance using standard protocols for the sample collection and the laboratory analysis by virus culture and reverse transcription-polymerase chain reaction (RT-PCR). During the first influenza season (2000/2001), 22 paediatricians collected one nose- and one throat-swab from each of the 586 children 0-6 years old recruited in the study. The QV test was carried out in the physician's office by primary care staff on the nose swab material. When compared with virus culture of the throat swab, the QV test had a sensitivity of 36.5%. In the following 2001/2002-influenza season, the performance of the QV test as a rapid laboratory screening assay was assessed. 342 children aged 0-14 years were enrolled with only one throat swab collected from each patient and sent to the laboratory where the QV, virus culture, and RT-PCR tests were performed. The results showed a better sensitivity (54.5%) of the test in comparison with virus culture and RT-PCR assays. The data indicate that rapid QV testing in the physician office setting, using these easily obtained samples, may be too insensitive to be useful for surveillance and for immediate clinical management of children presenting with influenza-like illness. Nevertheless, the QV test may be a valuable diagnostic tool if used in laboratory, as a rapid screening test. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122803     DOI: 10.1002/jmv.20086

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Comparison of polyurethane foam to nylon flocked swabs for collection of secretions from the anterior nares in performance of a rapid influenza virus antigen test in a pediatric emergency department.

Authors:  Kimberly A Scansen; Bema K Bonsu; Erin Stoner; Kathy Mack; Douglas Salamon; Amy Leber; Mario J Marcon
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

2.  Clinical evaluation of the SD Bioline influenza virus antigen test for rapid detection of influenza viruses A and B in children and adults during the influenza season.

Authors:  Young Yoo; Jang Wook Sohn; Dae Won Park; Jeong Yeon Kim; Hye Kyung Shin; Yoon Lee; Ji Tae Choung; Chang Kyu Lee; Min Ja Kim
Journal:  Clin Vaccine Immunol       Date:  2007-06-13

3.  Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.

Authors:  Valentina Germano; Maria Sofia Cattaruzza; John Osborn; Aurora Tarantino; Roberta Di Rosa; Simonetta Salemi; Raffaele D'Amelio
Journal:  J Transl Med       Date:  2014-03-22       Impact factor: 5.531

4.  Influenza-associated mortality among children - United States: 2007-2008.

Authors:  Patrick J Peebles; Rosaline Dhara; Lynnette Brammer; Alicia M Fry; Lyn Finelli
Journal:  Influenza Other Respir Viruses       Date:  2010-09-16       Impact factor: 4.380

5.  [Diagnosis of viral respiratory infections].

Authors:  M Leruez-Ville
Journal:  Rev Fr Allergol Immunol Clin       Date:  2006-10-05

6.  [Diagnosis of viral respiratory infections].

Authors:  M Leruez-Ville
Journal:  Arch Pediatr       Date:  2007-03-26       Impact factor: 1.180

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.